Peptide Science

How Do Peptides Work?

Understanding the science behind peptide action — receptor binding, signalling cascades, bioavailability, half-life, and how different administration routes affect their function.

The Lock and Key: Receptor Binding

Peptides work primarily by binding to specific receptors on the surface of cells. Think of this as a lock-and-key system: each peptide (the key) has a specific shape that fits into a particular receptor (the lock) on a cell's surface. When the peptide binds to its receptor, it triggers a cascade of events inside the cell.

This is why peptides are so specific in their actions. A peptide designed to bind to the GHRH receptor (like Sermorelin or CJC-1295) will stimulate growth hormone release but won't affect melanocortin receptors. A peptide like Melanotan II that activates multiple melanocortin receptors will affect pigmentation, appetite, and sexual function simultaneously.

The specificity of this interaction is determined by the peptide's amino acid sequence and three-dimensional shape. Even small changes to a peptide's structure can dramatically alter which receptors it binds to and how strongly.

Signal Transduction: What Happens After Binding

When a peptide binds to its receptor, it doesn't enter the cell directly. Instead, it triggers a process called signal transduction — a chain reaction of molecular events that transmits the message from the cell surface to the cell's interior.

Most peptide receptors are G-protein-coupled receptors (GPCRs). When a peptide binds to a GPCR, it causes a conformational change in the receptor that activates a G-protein on the inner side of the cell membrane. This G-protein then activates or inhibits secondary messenger molecules, which amplify the signal and trigger specific cellular responses.

Common signal transduction pathways activated by peptides include:

  • cAMP pathway: Used by GHRH (Sermorelin, CJC-1295) and ghrelin receptor agonists (Ipamorelin) to trigger growth hormone release
  • MAPK/ERK pathway: Involved in cell growth, differentiation, and survival — relevant to tissue repair peptides
  • PI3K/Akt pathway: Involved in cell survival and metabolism
  • NF-κB pathway: A key inflammatory pathway that peptides like TB-500 and BPC-157 can modulate

Bioavailability: Getting Peptides Where They Need to Go

Bioavailability refers to the proportion of a peptide that reaches the systemic circulation (and therefore its target) after administration. This is one of the biggest challenges in peptide research, because the body has robust systems for breaking down peptide chains.

Several factors affect peptide bioavailability:

  • Enzymatic degradation: Proteases and peptidases in the blood, gut, and tissues actively break down peptides. This is why many natural peptides have very short half-lives.
  • Gastric acid: The stomach's acidic environment denatures most peptides, making oral administration challenging. BPC-157 is notable for its exceptional gastric stability.
  • First-pass metabolism: Orally administered peptides must pass through the liver before reaching systemic circulation, where they may be further degraded.
  • Size and charge: Larger peptides have difficulty crossing cell membranes and biological barriers like the blood-brain barrier.

Half-Life: How Long Peptides Last

The half-life of a peptide is the time it takes for half of the administered dose to be eliminated from the body. This varies enormously between different peptides:

  • Natural GHRH: 2–7 minutes (very short)
  • Sermorelin: 10–20 minutes
  • CJC-1295 without DAC: ~30 minutes
  • Ipamorelin: ~2 hours
  • BPC-157: <30 minutes (after IV administration)
  • PT-141: ~2.7 hours
  • CJC-1295 with DAC: ~6–8 days
  • Semaglutide: ~7 days (165 hours)

Researchers have developed several strategies to extend peptide half-lives: amino acid substitutions (making the peptide resistant to specific enzymes), PEGylation (attaching polyethylene glycol chains), fatty acid conjugation (as in Semaglutide, which binds to albumin), and cyclisation (creating ring structures, as in Melanotan II).

Administration Routes

Subcutaneous Injection

The most common route for research peptides. The peptide is injected into the fatty tissue just below the skin, where it is absorbed into the bloodstream. Bioavailability is generally good (though varies by peptide) and absorption is relatively consistent.

Intramuscular Injection

Injection directly into muscle tissue. Absorption may be faster than subcutaneous due to greater blood flow in muscle tissue. Sometimes used for TB-500 and other systemic peptides.

Oral Administration

Challenging for most peptides due to gastric degradation. BPC-157 is an exception due to its gastric stability. Semaglutide (as Rybelsus®) uses a special formulation with an absorption enhancer (SNAC) to enable oral bioavailability. Oral AOD-9604 has also been studied in clinical trials.

Topical Application

Used primarily for small peptides like GHK-Cu that can penetrate the skin barrier. Effective for localised skin and wound healing applications but generally does not achieve significant systemic levels.

Intranasal

Some peptides can be administered as nasal sprays, allowing absorption through the nasal mucosa. This route can sometimes provide a path to the central nervous system, bypassing the blood-brain barrier.

The Feedback Loop: Self-Regulation

Many peptide systems in the body operate through feedback loops. This is particularly relevant for growth hormone secretagogues. When CJC-1295 or Ipamorelin stimulates GH release, the resulting increase in GH and IGF-1 levels triggers the hypothalamus to release somatostatin, which suppresses further GH release. This natural brake prevents excessive GH accumulation — a safety advantage over direct GH injection, which bypasses this feedback mechanism.

Why Understanding Mechanisms Matters

Understanding how peptides work is essential for:

  • Rational research design: Knowing a peptide's receptor targets and signalling pathways helps researchers design better experiments
  • Combination strategies: Understanding complementary mechanisms (like GHRH + GHRP synergy) enables more effective research protocols
  • Safety awareness: Understanding mechanisms helps predict potential side effects and interactions
  • Informed decisions: Knowing how a peptide works helps distinguish genuine science from marketing hype

For foundational context, start with What Are Peptides?. When you're ready to explore individual compounds, browse the Peptide Library or compare similar peptides in our head-to-head comparisons. Our blog also covers the latest research developments.

Research Disclaimer

The information presented on this page is for educational and research purposes only. This content does not constitute medical advice, diagnosis, or treatment recommendations. The compounds discussed are investigational and, unless otherwise noted, have not been approved for human therapeutic use by Health Canada or any other regulatory body. Always consult a qualified healthcare professional before considering any new treatment or substance.